Phosphodiesterase type 5 inhibitor

This page covers all Phosphodiesterase type 5 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PDE5.

Targets

PDE5

Phase 3 pipeline (1)

• Sublingual sildenafil · N4 Pharma UK Ltd. · Urology
  Sublingual sildenafil works by increasing blood flow to the penis to treat erectile dysfunction.

Patent intelligence

• phosphodiesterase type 5 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates